ORBi: Weiner Richard I. - Novel antiangiogenic peptide agents and their therapeutic and diagnostic use

Reference : Novel antiangiogenic peptide agents and their therapeutic and diagnostic use


	Document type :	Patent : Patent
	Discipline(s) :	Life sciences : Biochemistry, biophysics & molecular biology
	To cite this reference:	http://hdl.handle.net/2268/62853

Title :	Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
Language :	English
Author, co-author :	Weiner, Richard I. [ > > ]
	Martial, Joseph [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >]
	Struman, Ingrid [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >]
	Taylor, Robert [ > > ]
	Bentzien, Frauke [ > > ]
Publication date :	17-Apr-2008
Creation date :	2007-10-19
Publisher :	United States
Patent/publication number (10-11) :	US 2008/0090750 A1
Priority number (30) :	11/875,308
Report number :	B
Country :	United States
Depositor :	Weiner R., Martial J., Struman I., Taylor R., Bentzien F.
International classification (IPC) (51) :	A61K 38/00, A61P 43/00, C07K 16/00
European classification (ECLA) (52) :	U.S. Cl. 514/2, 530/300
International protection: country codes (81) :	US
European protection: country codes (84) :	EP
Keywords :	[en] Antiangiogenic ; Peptide
Abstract :	[en] The current invention concerns novel antiangiogenic peptides which correspond to about 10 to about 150 consecutive amino acids of N-terminal sequences of human growth hormones, human placental lactogen, human growth hormone variant hGH-V, and prolactin, and their use in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormalities of placental vascularization.
Research units :	Giga-Cancer
Permalink :	http://hdl.handle.net/2268/62853

There is no file associated with this reference.

All documents in ORBi are protected by a user license.